Sir, Uveitis is the most common ocular manifestation in acquired syphilis. 1 A course of intravenous penicillin G for 10-14 days is recommended for ophthalmic syphilis. 2 Despite its theoretical optimal adherence, the intravenous penicillin regimen is timeconsuming, uncomfortable and requires continuous intravenous administration. Alternative treatments are consequently required.
We report here a case of syphilitic uveitis successfully treated with oral doxycycline only.
An MSM, 56 kg, consulted at our institution for chronic visual discomfort, blurred vision and right-eye redness that started 1 year before. He had a medical history of psoriasis without arthritis treated with acitretin. Ocular examination evidenced panuveitis with episcleritis. Neurological examination was normal. Muco-cutaneous examination only revealed chronic psoriasis plaques. The blood Venereal Disease Research Laboratory (VDRL) test was positive (128 IU). The Treponema pallidum haemagglutination assay (TPHA) was also positive. HIV serology was negative. He refused hospitalization, lumbar puncture or intravenous penicillin G treatment. Hence he was given only oral doxycycline at 200 mg/day, divided into two equal doses, for 28 days. Posttreatment fundus and anterior chamber examination showed a complete regression of the uveitis, and VDRL follow-up (16 IU) 6 months later confirmed the favourable outcome. The patient did not relapse after 2 years of follow-up.
This case report highlights the potential usefulness of oral doxycycline for the treatment of syphilitic uveitis.
Ocular involvement is reported during early and late syphilis. Ocular manifestations include conjunctivitis, uveitis, scleritis, episcleritis, chorioretinitis, iritis and iridocyclitis. 3 Uveitis, as in our patient, is the most common ocular manifestation of syphilis in both HIV-positive and HIV-negative patients. 1 In a review of 143 cases of ocular syphilis, posterior uveitis was the most frequent presentation (55.2%), followed by panuveitis (25.2%) and anterior uveitis (19.6%). 4 Ocular neuroepithelial structure involvement, including retinitis or optic neuritis, is considered as neurosyphilis.
Intravenous penicillin G for 10-14 days is the gold standard treatment for syphilitic uveitis as well as for neurosyphilis. 2 Alternative treatments include the combination of procaine penicillin plus probenecid (not available in France) or ceftriaxone (recommended in case of penicillin allergy). 2 However, limited data suggest that either intramuscular or intravenous ceftriaxone at 2 g daily for 10-14 days could be efficient. 5, 6 Doxycycline has not been adequately evaluated for the treatment of ocular syphilis but our case report suggests it could be efficient.
Doxycycline, a derivative of tetracycline, has long been known to have spirochaetocidal activity. A daily dose of 200 mg (in two equal doses), given orally, is effective in early and late syphilis. Onoda 7 reported in 1979 a response rate of 100% for primary, 90% for early, 68% for late and 90% for congenital syphilis in adults with this regimen in an open study. Several controlled studies have since found similarly high rates of success between doxycycline/tetracycline and benzathine penicillin in the treatment of early syphilis. [8] [9] [10] Penetration of oral doxycycline (200 mg twice a day) into the CSF has been evaluated in five patients with latent syphilis or neurosyphilis. Drug levels in serum ranged from 3.6 to 8.6 mg/L (mean of 5.8 mg/L), whereas the mean doxycycline level in CSF was 1.3 mg/L (0.8-2.0 mg/L). The CSF penetration rate ranged from 11% to 56%, with a mean of 26%. 11 In another study, 100 mg daily doses of doxycycline for 2-10 days were associated with a spinal fluid level of 0.1-0.76 mg/L, the mean value (0.37 mg/L) corresponding to a 14% CSF penetration rate. 12 These results are consistent with those from a study of CSF penetration rates of doxycycline in patients with Lyme neuroborreliosis. Twelve patients were treated orally with 100 mg of doxycycline twice a day. The mean concentration in serum 5-8 days after the therapy started was 4.7 mg/L 2-3 h after the last drug administration. The corresponding level for CSF was 0.6 mg/L. Penetration into the CSF varied from 8% to 35% of concentration in plasma, with a mean of 15%. 13 There is no controlled study evaluating the efficacy of doxycycline in ocular syphilis. Only two cases of syphilitic uveitis in which treatment included oral doxycycline have been reported. Both patients were previously treated with intravenous penicillin G for 4 weeks.
14 Therefore, the good outcome could be due to either penicillin or doxycycline.
Poor data are available concerning doxycycline ocular penetration. Norris and Edmonson 15 determined a tetracycline MIC of 0.2 mg/L for T. pallidum using an in vitro culture procedure. Clinical relevance of such pharmacokinetic data should be tested in a therapeutic trial.
Oral doxycycline could improve the clinical management of patients diagnosed with ophthalmological syphilis (with no evidence for neurosyphilis), avoiding the intravenous route, and in a more cost-effective way. However, comparative studies are needed to assert this efficacy, including in HIV-positive patients. The duration of 28 days we chose was empirical and should be investigated pharmacokinetically.
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